QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aerovate-therapeutics-stockholders-approve-proposed-merger-with-jade-biosciences-board-approves-1-for-35-reverse-stock-split

—Aerovate Board of Directors approves 1-for-35 reverse stock split—WALTHAM, Mass., April 21, 2025 /PRNewswire/ -- Aerovate Ther...

 aerovate-therapeutics-declares-special-cash-dividend-of-696m-or-an-estimated-240-per-share

Aggregate cash dividend of $69.6 million, or an estimated $2.40 per shareWALTHAM, Mass., April 9, 2025 /PRNewswire/ -- Aerovate...

 aerovate-therapeutics-and-privately-held-jade-biosciences-have-entered-into-a-definitive-merger-agreement-for-an-all-stock-transaction-the-resulting-entity-will-focus-on-advancing-jades-portfolio-of-biologics-including-jade-001-for-iga-nephropathy

Merger to create a company focused on advancing Jade Biosciences' portfolio of novel therapies that aim to redefine the sta...

 aerovate-therapeutics-to-explore-strategic-alternatives-which-may-include-but-are-not-limited-to-an-acquisition-merger-reverse-merger-business-combination-liquidation-or-other-transaction

Aerovate Therapeutics, Inc. (NASDAQ:AVTE), which previously announced it was halting enrollment and shutting down the Phase 3 p...

 evercore-isi-group-downgrades-aerovate-therapeutics-to-in-line-lowers-price-target-to-2

Evercore ISI Group analyst Liisa Bayko downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Outperform to In-Line and lowers ...

 guggenheim-downgrades-aerovate-therapeutics-to-neutral

Guggenheim analyst Vamil Divan downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Neutral.

 wells-fargo-downgrades-aerovate-therapeutics-to-equal-weight-lowers-price-target-to-2

Wells Fargo analyst Tiago Fauth downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Overweight to Equal-Weight and lowers th...

 td-cowen-downgrades-aerovate-therapeutics-to-hold

TD Cowen analyst Joseph Thome downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Hold.

 jefferies-downgrades-aerovate-therapeutics-to-hold-lowers-price-target-to-2

Jefferies analyst Eun Yang downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Hold and lowers the price target from ...

 btig-downgrades-aerovate-therapeutics-to-neutral

BTIG analyst Julian Harrison downgrades Aerovate Therapeutics (NASDAQ:AVTE) from Buy to Neutral.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION